Scientists dive deep into skull base tumors to find new clues
NCT ID NCT03759717
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study collects and analyzes tumor samples from 4000 people with skull base tumors. Researchers will study the genetic and molecular makeup of these tumors to learn how they form and resist treatment. The goal is to identify new targets for future therapies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward new drug targets for treating skull base tumors.
- What could go wrong
- This is an observational study, not a treatment trial. It is early-stage research that may not directly lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELLULAR PATHOLOGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15213, United States